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OBJECTIVES: The International Prostate Symptom Score
(IPSS), a condition-speciﬁc questionnaire originally addressed to
men, comprises seven items investigating symptoms (summed
into a total score), plus 1 item on quality of life (QoL). The IPSS
was translated into Italian and adapted to women. The so-
obtained W-IPSS was thus validated by the FLOW study group
in a sample of Italian women with lower urinary tract symptoms
(LUTS). METHODS: The validation process consisted of
forward and backward translation, test of comprehension, dis-
criminant validity and test-retest reliability. A ﬁrst set of women
was interviewed after ﬁlling-in the questionnaire and a compre-
hension rate was built as the percentage of correctly understood
questions and pre-coded answers. A case-control study was then
performed. Women aged ° 18 year affected by LUTS for at
least three months and with negative dipstick were consecutively
enrolled as cases. Controls were deﬁned as healthy women of
comparable age. In order to evaluate reliability, cases were
retested after seven days from baseline and a correlation analy-
sis was performed (Pearson’s r). Discriminant validity was
assessed by comparing the scores of cases and controls with
ANOVA. RESULTS: During the translation process the QoL
question about “prostate symptoms” was changed into “urinary
symptoms” to adapt the IPSS to a female population (now “W-
IPSS”). The comprehension rate obtained on 15 women was
86%. Eighty cases and 80 controls were then enrolled at base-
line. All cases were eligible for the test-retest. Pearson’s coefﬁ-
cient between ratings was 0.81 for the symptom score and 0.89
for QoL. Cases and controls were discriminated by ANOVA (p
< 0.001) for all items. CONCLUSION: Women-IPSS shows
overall a satisfactory comprehension rate, a good test-retest reli-
ability and high discriminant validity.
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OBJECTIVE: Clinicians in charge of Stress Urinary Incontinence
(SUI) patients miss speciﬁc tools taking into account patients’
perspective to support treatment decision. Our aim was to
develop a global medical judgment scale to assess therapeutic
response. METHODS: The concepts useful to assess SUI treat-
ment outcomes were identiﬁed from a literature review and 30
clinician interviews. A test version of the pragmatic assessment
form (PAF) was developed. Eight clinicians involved in the care
of SUI were interviewed to assess concept relevance, compre-
hensiveness, validity, accessibility to source information, clarity,
applicability to various situations in real life, usefulness in clin-
ical practice to form global medical judgment. The PAF was
updated accordingly. Ten SUI patients reviewed the PAF for
concept relevance, reliability and applicability in clinical prac-
Y¢
tice. RESULTS: Eight broad concepts covering symptom and
functional status, impact on daily life activities, well-being,
coping, satisfaction and expectations were included in the test
PAF. Seven of 8 clinicians found the PAF complete, relevant, and
speciﬁc to SUI, clear and valid to support medical judgment. The
clinicians were happy to have an assessment guide to support
judgment, but did not request a formal scoring procedure to
support decision. Satisfaction was divided into treatment beneﬁt,
undesirable effects and constraints. Patient’s intention was
added. After validation by 10 SUI patients, the pilot version of
the PAF was ﬁnalised in double A4 format including instructions.
Concept elicitation can be pragmatic for clinical practice, or
standardized for clinical research. CONCLUSION: This short,
simple and pragmatic composite tool will help the clinicians to
easily manage the complexity of patients’ perspective by com-
prehensively covering the relevant outcomes to assess therapeu-
tics and support medical decision making in SUI. Its properties
in clinical practice and clinical research will be assessed in spe-
ciﬁc validation studies.
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OBJECTIVE: To compare results of two surgical procedures for
stress urinary incontinence (SUI) using conventional urodynamic
study (objective measure) and the ICIQ-UI SF questionnaire
(patient’s perspective outcome measure). METHODS: Prospec-
tive study of 120 women with urodynamic diagnosis of SUI who
received treatment with tension free vaginal tape by retropubic
tract (RP) or by transobturador tract (TO). All the patients
underwent urogynaecological history, physical examination,
ICIQ-UI SF and urodynamic study. The treatment outcome was
evaluated 6–12 months later by urodynamic study and ICIQ-UI
SF. Patients were divided into 3 groups, “cured”, “improved” or
“failed treatment”, according to the observed stress leakage
during postoperative ﬁlling cystometry. According to the ICIQ-
UI SF post-treatment score, patients were also divided into 3
groups: “cured” when it was 0; “improved” when it was lower
than pre-treatment and “failed treatment” when it was equal or
higher than pre-treatment score. RESULTS: Tension free vaginal
tape (RP) was applied to 77 women (64.2%) and (TO) to 43
(35.8%). No statistical differences in demographic and basal
data were found between the two groups. According to the post-
treatment urodynamic evaluation, 74 patients (96%) were
“cured or improved” in the RP group and 39 (91%) in the TO
group (p = 0.208). According to the ICIQ-UI SF, 71 (92.2%)
were “cured or improved” in the RP and 37 (86%) in the TO
group (p = 0.221). Considering cured and improved patients
independently, in the RP group 66 patients showed no leakage
during postcystometry stress test (86%) and 26 were cured
(61%) in the TO group (p.003). According to the ICIQ-UI SF
only 55 (71.4%) felt cured of their symptoms in the RP vs. 22
(51.2%) in the TO group. CONCLUSIONS: There are impor-
tant differences when evaluating the treatment outcome in
urinary incontinence depending on what is considered a good
outcome (cure improvement vs. cure alone) and on what method
is used to assess the outcome (urodynamic study vs. self-reported
questionnaire).
